OMER
Omeros·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
OMER fundamentals
Omeros (OMER) released its earnings on Nov 13, 2025: revenue was 0 (YoY 0.00%), missed estimates; EPS was -0.34 (YoY +46.88%), beat estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.34
+46.88%
Report date
Nov 13, 2025
OMER Earnings Call Summary for Q3,2025
- $2.1B Strategic Deal: Novo Nordisk collaboration provides $240M upfront and $100M near-term milestones.
- Financial Turnaround: Reduced debt by 80% to $17.1M; 2027 cash flow positive.
- YARTEMLEA Launch: FDA approval expected Q4; NTAP coverage secured.
- Pipeline Expansion: MASP-2 antibody (Phase 2), PDE7, and T-CAT programs advancing.
EPS
Revenue
Revenue & Expenses
Key Indicators
Omeros (OMER) key financial stats and ratios, covering profitability, financial health, and leverage.
Omeros (OMER)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Omeros (OMER)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Omeros (OMER)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Omeros (OMER) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Omeros (OMER) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
Did Omeros beat or miss consensus estimates last quarter?What were the key takeaways from Omeros's earnings call?What is the market's earnings forecast for Omeros next quarter?What does Omeros do and what are its main business segments?What is Omeros's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Omeros year over year?What factors drove the changes in Omeros's revenue and profit?What guidance did Omeros's management provide for the next earnings period?
